Ion channels are targets for selective drugs
Ion channels constitute a large and diverse group of membrane
proteins that function as electrical signal transducers, and they
govern the electrical properties of all living cells. For example,
the coordinated activity of several ion channels is the mechanism
underlying action potentials in excitable cells, such as those in
the heart and brain.
Ion channels are in general heteromultimeric integral membrane
proteins constituting water filled passageways for ions across the
phospholipid bilayer membrane. The physical pore is shaped by an
assembly of several subunits, and the pore is lined with
hydrophilic amino acid residues. A narrow region of the pore is
typically charged and constitutes a 'selectivity-filter' that
determine which ions can pass through the pore.

Ion channels may open and close in response to membrane
potential (voltage-gated ion channels) or chemical (ligand-gated
ion channels) stimuli.
Classification of Ion Channels
Each ion channel is characterized by its ion selectivity sequence.
It may be highly specific for a single ion or it may be less
specific, conducting a few or several different ions. The
selectivity is reflected in the common classification of the
channels:
K+ channels
Na+ channels
Ca2+ channels
Cl- channels
non-selective cation channels
Functionally, ion channels are broadly divided into voltage- and
ligand-gated channels, referring to the type of physiological
stimulus that activates the channel.
Diseases linked to Ion Channels
A multitude of human and animal diseases are caused by dysfunction
of ion channels. This may be genetic, i.e. caused directly by
mutations in genes coding for ion channels. Such diseases are
called 'channelopathies'. Examples of channelopathies are cystic
fibrosis, epilepsy, and cardiac arrhythmias, e.g. the long QT
syndrome. Also, diseases may result from defects caused by
mutations in genes coding for proteins which regulate ion
channels.
Alternatively, ion channels may be involved in non-genetic
diseases, e.g. diarrhea, which is mediated by toxicological effects
on ion channel function.

Ion channels as drug targets
The search for new, potent and selective drugs that
interact with specific ion channels is strongly technology driven
and focused on high-throughput screening. Active substances from
these high throughput screens are further analyzed in functional
studies, such as patch clamp. This development towards screening at
the molecular level has been enabled primarily by: 1) the cloning
and expression of relevant ion channels in cell lines and 2) novel
biological high-throughput screening techniques.
Technologies for ion channel
characterization
The only direct way of validating the effect of a chemical entity
on an ion channel is to measure the ionic current through the
channel and determine whether the compound causes a change in this
current. The patch clamp technique (link) has proven extremely
useful in revealing many aspects of ion channel function. However,
traditional patch clamp has serious shortcomings in pharmaceutical
discovery and screening, because the throughput is low, and it
requires highly specialized personnel.
With the advent of automated patch clamp equipment these
shortcomings are largely abolished. The QPatch allows an
operator without prior electrophysiological knowledge to conduct
experiments. With the help of the highly skilled application
scientists at Sophion, or a skilled electrophysiologist in your
staff - you too can be a patch clamper!